Expanding roles of SGLT-2 inhibitors

Shervin Zandi, Khalid Azzam

Dr Shervin Zandi, assistant clinical professor at the Department of Medicine, McMaster University, joins Dr Khalid Azzam during the Chair's Medical Grand Rounds to present a comprehensive review of the expanding role of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in the treatment of diabetes, heart failure, and chronic kidney disease, as well as to discuss special considerations and precautions associated with these agents. The webinar was recorded on October 14, 2021.

See also

We would love to hear from you

Comments, mistakes, suggestions?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.